logo
Terrifying rise of fungal infection sweeping US

Terrifying rise of fungal infection sweeping US

Daily Mail​04-06-2025
The killer fungi that led to the tragic death of Hollywood stylist Jesus Guerrero is exploding among people who previously have not been at risk.
Guerrero, known for working with stars like Kylie Jenner and Jennifer Lopez, died at a Los Angeles hospital in February.
The medical examiner confirmed the celebrity stylist died from two deadly fungal infections: Pneumocystis jirovecii pneumonia (PJP) and Cryptococcus neoformans, most likely a complication of AIDS, which was listed as a secondary cause of death. It is not known how he became infected.
People with HIV or AIDS historically represent the largest population affected by the fungi, because of their weakened immune systems.
However, cases are now alarmingly rising among broader populations, including non HIV or AIDS-immunosuppressed patients.
North-American cryptococcal cases have jumped 62 percent since 2014, while UK Pneumocystis infections doubled.
Aside from those battling HIV, these infections can more easily strike other people with weakened immunity, including patients undergoing cancer treatments, those who are on immunosuppressants after an organ transplant - and even those with a Covid infection.
'These individuals might not be on doctors' radar for infections like PJP, so they often aren't given preventive treatments the way HIV-positive patients are,' Dr Ehsan Ali, an internal medicine specialist. 'That delay in recognition and care can be life-threatening.
The killer fungi that led to the death of Hollywood stylist Jesus Guerrero is exploding among people who previously have not been at risk
Guerro, pictured with one of his former clients Kylie Jenner, succumbed to Pneumocystis jirovecii pneumonia (PJP) and Cryptococcus neoformans, two fungal infections which are on the rise
He likely developed the infections due to being HIV positive as AIDS was listed a secondary cause of death, however doctors are warning the infections are reaching other immunocompromised patients who don't have HIV or AIDS
'The growing number of non-HIV patients developing these infections is a sign that we need to rethink how we monitor and protect people with suppressed immune systems.
'Just because someone doesn't have HIV doesn't mean they're not at risk, and catching these infections early can be the difference between recovery and tragedy.'
Pneumocystis jirovecii is a silent airborne killer whose spores float undetected. It attacks the lungs with deadly inflammation that drowns victims in fluid and deprives the body of oxygen, leading to multi-organ failure.
Cryptococcus, meanwhile, hides in soil and bird droppings, invading lungs before migrating to the brain to cause fatal meningitis. There it unleashes a double onslaught of meningitis and encephalitis - brain swelling - often with fatal consequences.
A trio of telltale signs of PJP – a dry cough (95 percent of patients), trouble breathing, and a low-grade fever (around 80 percent) – is a key indication of the fungal infection in the lungs.
Since its discovery in the 1980s, PJP has been considered a disease solely of the immunocompromised, particularly in people suffering from AIDS.
While typically believed to be a condition associated with HIV/AIDS, Dr Ali said patients undergoing chemotherapy, recovering from organ transplants, or taking medications like steroids or immunosuppressants for conditions like lupus, rheumatoid arthritis, or Crohn's disease, represent a growing patient population.
In 2005, three-year-old Eliza Jane [center] died from pneumocystis pneumonia caused by the fungus Pneumocystis jirovecii
Eliza Jane began vomiting and within hours, she collapsed. Tests revealed a severe case of pneumonia that had advanced past the ability to treat. Eliza Jane died the next day.
In 2005, three-year-old Eliza Jane Scovill, who later tested HIV-positive, died from a pneumonia caused by Pneumocystis jirovecii.
Eliza Jane was born to a mother with HIV who denied the virus caused AIDS and so did not test her daughter for the condition.
This which severely weakened the little girl's immune system and left her susceptible to infection.
The youngster had been suffering from common cold symptoms and collapsed on May 15, 2005. She died the next day and an autopsy revealed she'd had pneumonia for weeks.
But PJP has been shown to be even deadlier in non-HIV-positive patients with weakened immune systems.
Global death rates in people with weakened immune systems but without HIV range from 30 to 60 percent, compared to 10 to 20 percent of HIV patients.
Meanwhile, the global mortality rate of Cryptococcus neoformans infection is high in people with HIV – roughly 41 to 61 percent — and the early warning signs can be easy to miss.
Doctors say it typically starts out with headaches, fever, cough, and shortness of breath. As it spreads, it can cause stiff neck, nausea, confusion, and sensitivity to light — signs the infection has reached the brain and triggered life-threatening meningitis.
Cryptococcus hides in soil and bird droppings, invading lungs before migrating to the brain to cause fatal meningitis
Your browser does not support iframes.
Around 19 percent of AIDS-related deaths are due to meningitis caused by Cryptococcus neoformans.
Scientists are still trying to pinpoint the exact cause of the rising rates of fungal infections.
The number of people with weakened immune systems is on the rise as rates of chronic illness and disease increase.
Cancer rates and people being treated for the disease are steadily ticking up, translating to a growing population of immunocompromised people.
Climate change also has a major role to play - with rising global temperatures potentially forcing fungi to grow in places it previously hasn't or evolve to become more adaptable and resistant to treatments.
Robin May, a professor of infectious diseases at the University of Birmingham in England, said: 'Since we have far fewer drugs against fungi than we do against bacteria, the antifungal arsenal is very limited, and resistance to only one or two drugs can render a fungus essentially untreatable.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump is checked for swelling in legs and was diagnosed with a common condition in older adults
Trump is checked for swelling in legs and was diagnosed with a common condition in older adults

The Independent

time8 minutes ago

  • The Independent

Trump is checked for swelling in legs and was diagnosed with a common condition in older adults

White House press secretary Karoline Leavitt on Thursday read a doctor's letter about President Donald Trump that she said was intended to dispel health concerns about the swelling in his ankles and a makeup-covered hand. Leavitt said Trump noticed 'mild swelling' in his lower legs and was evaluated by the White House medical unit. She said the tests showed 'no evidence of deep vein thrombosis or arterial disease,' but that Trump has 'chronic venous insufficiency," a fairly common condition in older adults when little valves inside the veins that normally help move blood against gravity up the legs gradually lose the ability to work properly. Leavitt said the issue is common in people older than age 70. Trump turned 79 last month. People often are advised to lose weight, walk for exercise and elevate their legs periodically, and some may be advised to wear compression stockings. Severe cases over time can lead to complications including lower leg sores called ulcers. Blood clots are one cause, but Leavitt said that was tested for and ruled out. She also said bruising on Trump's hand that has been covered up by makeup is 'consistent' with irritation from his 'frequent handshaking and the use of aspirin.' Leavitt said 'the president remains in excellent health.' She promised to make the doctor's letter public.

House votes on trio of cryptocurrency bills aimed at legitimizing the industry
House votes on trio of cryptocurrency bills aimed at legitimizing the industry

The Independent

time8 minutes ago

  • The Independent

House votes on trio of cryptocurrency bills aimed at legitimizing the industry

The House is voting on a trio of bills Thursday intended to boost the legitimacy of the cryptocurrency industry with new regulations as President Donald Trump has pushed to make the U.S. the ' crypto capital of the world.' One of the bills, which would regulate a type of cryptocurrency called stablecoins, has already passed the Senate with broad bipartisan support and will head to Trump's desk if it passes the lower chamber. The other two — legislation to address cryptocurrency market structure and a bill to prohibit the Federal Reserve from issuing a central bank digital currency — have yet to be passed in the Senate. The stablecoin bill sets initial guardrails and consumer protections for the cryptocurrency, which is tied to a stable asset, often the U.S. dollar, to reduce price volatility. It passed the Senate with bipartisan support in June. 'Around the world, payment systems are undergoing a revolution,' said House Financial Services Chair French Hill of Arkansas as lawmakers debated the stablecoin legislation Thursday morning. Hill said the bill will 'ensure American competitiveness and strong guardrails for our consumers.' After Trump declared it 'crypto week,' the bills were stalled for more than a day amid disagreements among House Republicans about how to combine the legislation. In the end, GOP leaders put the three bills for a separate vote, leaving the fate of the other two bills unclear. The internal dissent could foreshadow challenges ahead for the more sweeping crypto legislation that Trump has demanded and the industry has poured millions into advancing. The stablecoin measure is seen by lawmakers and the industry as a step toward adding legitimacy and consumer trust to a rapidly growing sector. Treasury Secretary Scott Bessent said in June that the legislation could help that currency 'grow into a $3.7 trillion market by the end of the decade.' The bill outlines requirements for stablecoin issuers, including compliance with U.S. anti-money laundering and sanctions laws, and mandates that issuers hold reserves backing the cryptocurrency. Without such a framework, Republicans on the Senate Banking Committee in a statement warned, 'consumers face risks like unstable reserves or unclear operations from stablecoin issuers." Despite some bipartisan support, the bill faced pushback as it made its way through Congress. Democrats felt that it did little to address Trump's personal financial interests in the crypto space. 'No one should be surprised that these same Republicans' next order of business is to validate, legitimize, and endorse the Trump family's corruption and efforts to sell the White House to the highest bidder,' said California Rep. Maxine Waters, the top Democrat on the Financial Services panel. A provision in the stablecoin bill bans members of Congress and their families from profiting off stablecoins. But that prohibition does not extend to the president and his family, even as Trump builds a crypto empire from the White House. In May, the Republican president hosted a private dinner at his golf club in Virginia with top investors in a Trump-branded meme coin. His family holds a significant stake in World Liberty Financial, a crypto project that launched its own stablecoin, USD1. Trump reported earning $57.35 million from token sales at World Liberty Financial in 2024, according to a public financial disclosure released in June. A meme coin linked to him has generated an estimated $320 million in fees, though the earnings are split among multiple investors. Some Democrats also criticized the bill for creating what they see as an overly weak regulatory framework that could pose long-term financial risks. They've also raised concerns that the legislation opens the door for major corporations to issue their own private cryptocurrencies. 'If this bill passes, it will allow Elon Musk and Mark Zuckerberg to issue their own money. The bill still permits Big Tech companies and other conglomerates to issue their own private currencies,' said Massachusetts Sen. Elizabeth Warren, the top Democrat on the Senate Banking Committee. ___

Juul will be allowed to sell e-cigarettes ending long fight over flavored tobacco on store shelves
Juul will be allowed to sell e-cigarettes ending long fight over flavored tobacco on store shelves

The Independent

time8 minutes ago

  • The Independent

Juul will be allowed to sell e-cigarettes ending long fight over flavored tobacco on store shelves

Vaping brand Juul Labs can continue to sell its e-cigarettes and refill cartridges, the Food and Drug Administration announced Thursday. The decision comes after the company struggled for years against heightened regulatory scrutiny and intense backlash as the brand's flavored pods became popular amongst young people, contributing to the rise in teen vaping. Despite this, the FDA ruled that Juul's studies show its e-cigarettes are less harmful for adult smokers, who can benefit from switching from cigarettes to vaping. The decision applies to both tobacco and menthol-flavored versions of the e-cigarettes, which are used with nicotine-filled cartridges sold in two different strengths. 'This is an important milestone for the company and I think we made a scientifically sound case for the role that menthol can play in e-vapor,' Juul CEO K.C. Crosthwaite told The Associated Press. Ahead of the decision, Juul attempted to drive away some of its teen consumers by discontinuing several fruit and candy flavors that were favored by that demographic. The FDA had ordered the company to remove its products from the market in June 2022, but quickly changed course after Juul pushed back in court. The announcement is also not an approval or endorsement of Juul's products, and the FDA reiterated that people who do not smoke should not use Juul or any other e-cigarettes.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store